Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humacyte (HUMA) Other Non-Current Assets (2024 - 2025)

Humacyte has reported Other Non-Current Assets over the past 2 years, most recently at $672000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $672000.0 for Q4 2025, down 98.66% from a year ago — trailing twelve months through Dec 2025 was $672000.0 (down 98.66% YoY), and the annual figure for FY2025 was $672000.0, down 98.66%.
  • Other Non-Current Assets for Q4 2025 was $672000.0 at Humacyte, roughly flat from $672000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for HUMA hit a ceiling of $50.2 million in Q4 2024 and a floor of $672000.0 in Q3 2025.